Virtual West Oncology Conference

 

Videos
25:11

Virtual West Oncology Conference

66 y/o Male With DLBCL: R-CHOP, Revlimid Upfront, Curative Options, R-GemOx, CAR-T, Relapse After ASCT

FEATURING Jason Chandler, Neha Mehta-Shah, Abdulraheem Yacoub, Carlos Bachier
  • 17 views
  • March 11, 2021
13:21

Virtual West Oncology Conference

72 y/o Female With High WBCs, Low Platelet Count & Cytopenia: Option of ASCT, ESA, Luspatercept, HMAs, Progression to Leukemia

FEATURING Jason Chandler, Neha Mehta-Shah, Abdulraheem Yacoub, Carlos Bachier
  • 81 views
  • March 11, 2021
10:41

Virtual West Oncology Conference

ASH Updates on CML: Pathogenesis and Outcomes, 1L Therapy Choices, Treatment Free Remission

FEATURING Abdulraheem Yacoub
  • 175 views
  • March 11, 2021
  • 1
15:01

Virtual West Oncology Conference

ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythropoiesis in LR-IR Disease? Is EFS Better With Pevonedistat+Aza vs. Aza Alone in HR-MDS? Should We Combine Ven+Aza?

FEATURING Jason Chandler
  • 118 views
  • March 11, 2021
17:39

Virtual West Oncology Conference

2021 Update on Breast Cancer Brain Metastases: Current Treatment Options and Challenges

FEATURING Lee Schwartzberg
  • 268 views
  • March 10, 2021
  • 2
22:48

Virtual West Oncology Conference

40 y/o Premenopausal Woman With HR+ eBC: What Is the Best Local Therapy? Should We Use Genomic Assay to Aid Decision? How Should We Approach Symptom Control After Ovarian Suppression+Anastrozole?

FEATURING Lee Schwartzberg, Neelima Vidula, Terry Mamounas, Kristina Mirabeau-Beale, Jane Meisel, Gregory Vidal
  • 13 views
  • March 9, 2021
14:33

Virtual West Oncology Conference

59 y/o Woman With HER+ eBC: Neoadjuvant Chemo, Post-neoadjuvant Systemic Treatment/RT, CNS & Liver Metastases

FEATURING Lee Schwartzberg, Neelima Vidula, Terry Mamounas, Kristina Mirabeau-Beale, Jane Meisel, Gregory Vidal
  • 124 views
  • March 9, 2021
16:11

Virtual West Oncology Conference

Genomic Expression Panels for Chemo in eBC: Does Adjuvant Chemo Show IDFS Benefit in ER+/HER2- Patients? Is ET Useful? How Can We Use RSClin Score to Individualize Prognosis? When Can We Safely Omit Chemo?

FEATURING Terry Mamounas
  • 127 views
  • March 9, 2021
  • 1
16:46

Virtual West Oncology Conference

2021 Updates on mTNBC: Do Olaparib/Talazoparib Improve PFS Compared to Chemo? Is Atezo+Nab-Paclitaxel Beneficial for OS/PFS? Should We Use Sacituzumab Govitecan in R/R Disease?

FEATURING Neelima Vidula
  • 62 views
  • March 9, 2021
  • 1
20:35

Virtual West Oncology Conference

2021 Update on EGFR Resistant NSCLC: How Effective Are Current Options? What Is the Role of ADCs?

FEATURING Shayma Kazmi
  • 494 views
  • March 8, 2021
  • 4
06:21

Virtual West Oncology Conference

ASH Updates on CAR-T in R/R DLBCL: When to Consider? Can It Be Used Earlier in High-Risk Patients or in First Salvage?

FEATURING Neha Mehta-Shah
  • 166 views
  • March 8, 2021
  • 1
07:20

Virtual West Oncology Conference

ASH Updates on Lymphomas: Bispecific Antibodies for Patients Who Relapse After CAR-T or ASCT, CAR-T & Bispecific Antibodies for Indolent Lymphomas

FEATURING Neha Mehta-Shah
  • 100 views
  • March 8, 2021
07:11

Virtual West Oncology Conference

ASH Updates on Relapsed/Refractory Hodgkin Lymphomas and PTCL: What Are Our Options?

FEATURING Neha Mehta-Shah
  • 18 views
  • March 8, 2021
30:58

Virtual West Oncology Conference

Non-Muscle Invasive Urothelial Carcinoma Case Disussion: 62 y/o Male With High-Grade Ta Disease - Risk Category, Chances of Recurrence/Progression, BCG-Refractory/BCG-Non-Responsive Differences, Role of RT, mUC Development

FEATURING Brad Somer, Daniel Vaena, Jean Hoffman-Censits, Amy Luckenbaugh, Holger Gieschen, Heather Greene
  • 201 views
  • March 7, 2021
  • 2
18:56

Virtual West Oncology Conference

Advanced NSCLC Case Expert Discussion: Incurable Recurrent Stage 3b Disease, KIF5B/RET+, After Concurrent CRT+Immune Checkpoint Inhibitor Maintenance

FEATURING Erminia Massarelli, Shayma Kazmi, Jason Porter, Erin Gillaspie, Katie Keane
  • 329 views
  • March 5, 2021
  • 1
13:35

Virtual West Oncology Conference

mNSCLC Case Expert Discussion: Left Lung SCC With Bone Metastases - Treating Oligometastatic Disease, EGFR TKI vs. IO

FEATURING Erminia Massarelli, Shayma Kazmi, Jason Porter, Erin Gillaspie, Katie Keane
  • 167 views
  • March 5, 2021
  • 1
15:58

Virtual West Oncology Conference

2021 Updates on mNCSLC: Single Agent IO and Combination Therapy Approaches in the 1L Setting

FEATURING Jason Porter
  • 344 views
  • March 5, 2021
  • 2
15:01

Virtual West Oncology Conference

2021 Updates on NMIBC: Low-Grade vs. High-Grade pTa, pT1, Carcinoma in Situ, Intravesical Chemo (Mitomycin C, Gemcitabine), BCG, Refractory High-Grade Disease

FEATURING Amy Luckenbaugh
  • 45 views
  • March 5, 2021
18:41

Virtual West Oncology Conference

2021 Updates in RCC: Surveying Data for SWOG 1500, Belzutifan, CLEAR, and CM9ER

FEATURING Brad Somer
  • 169 views
  • March 5, 2021
06:49

Virtual West Oncology Conference

Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Efficacy and Safety of Crizotinib, Sotorasib Data in KRAS G12C NSCLC

FEATURING Erminia Massarelli
  • 54 views
  • March 5, 2021
  • 1
16:08

Virtual West Oncology Conference

2021 Updates on RC: Does Neoadjuvant Chemo Improve Outcomes? Who Needs Surgery/Radiation?

FEATURING Noam Vanderwalde
  • 89 views
  • March 5, 2021
15:43

Virtual West Oncology Conference

2021 Update on ctDNA Analysis in Colorectal Cancer: Surveying Application in Adjuvant Treatment and Post-Treatment Response Settings

FEATURING Gregory Botta
  • 517 views
  • March 5, 2021
  • 3
14:54

Virtual West Oncology Conference

Borderline Resectable Pancreatic Cancer Updates: What Are the Anatomic/Non-Anatomic Considerations? Does RT Help and What Is the Appropriate Dose?

FEATURING Paxton Dickson
  • 18 views
  • March 5, 2021
22:30

Virtual West Oncology Conference

2021 Updates on Advanced Bladder Cancer: What Agents Are Available in the 1L Setting and Beyond? How Promising Are Novel Combinations?

FEATURING Jean Hoffman-Censits
  • 69 views
  • March 5, 2021
08:44

Virtual West Oncology Conference

2021 Update on ADT Intensification for mCSPC: What Are the Benefits & Survival Rates of Apalutamide? When It Should Be Administered for Better Outcomes?

FEATURING Daniel Vaena
  • 41 views
  • March 5, 2021
12:40

Virtual West Oncology Conference

2021 Highlights on PARPi for mCRPC & PSMA Imaging: What Is the Efficacy and PFS/OS Effect of Olaparib/Rucaparib? How Does PSMA PET/CT Impact SRT Planning?

FEATURING Daniel Vaena
  • 147 views
  • March 5, 2021
06:27

Virtual West Oncology Conference

Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approved Selpercatinib & Pralsetinib

FEATURING Erminia Massarelli
  • 67 views
  • March 4, 2021
05:28

Virtual West Oncology Conference

2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease

FEATURING Erminia Massarelli
  • 143 views
  • March 4, 2021